Class action settlement earmarks money for consumers

If you bought the prescription antibiotic Augmentin from Jan. 4, 2000 to April 30, 2004, you could be eligible for a payment from a class action settlement. GlaxoSmithKline agreed to pay $29 million to settle an antitrust lawsuit over whether it improperly blocked manufacturers from selling generic Augmentin.

Fifty-five percent of the settlement is earmarked for consumers. The rest will go to third-party payors, such as health insurance companies.

To find out more, visit www.augmentinlitigation.com.